Skip to main content

Table 3 Results of the Centre of Disease Control and Prevention antinuclear antibodies reference sera

From: Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus

Sample SmD3 SmD1 RNP/Sm ELISA SmD ELISA Autoantibody [24, 35]
1 10.3 115.6 3.0 1.9 dsDNA, ssDNA, histone, (weak) Sm
2 1.4 11.4 0.3 0.3 (weak) SS-A, SS-B
3 1.9 18.1 7.3 1.6 (weak) Sm, SS-A, SS-B
4 2.5 19.6 7.5 0.4 U1 RNP
5 >100.0 >200 7.8 6.0 Histone, Sm
6 3.1 14.5 0.5 0.3 Nucleolar
7 0.0 7.7 0.2 0.3 SS-A
8 0.1 6 0.2 0.3 Centromere
9 1.7 18 0.2 0.3 Scl-70
10 0.5 3.1 0.1 0.1 Jo-1
11 0.6 11.9 0.3 0.4 PM/Scl complex
  1. Bold data indicate positive test result in the respective test. PM/Scl complex = polymyositis/scleroderma overlap complex